Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT01401322 · TERMINATED
Trial details
- NCT number
- NCT01401322
- Sponsor
- Stanford University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.